# Kura Oncology, Inc.: Form 8-K, filed Jul 1, 2025

- Company: [Kura Oncology, Inc.](/companies/kura.md) (CIK 1422143)
- Form: 8-K
- Filed: 2025-07-01
- Accepted by EDGAR: Jul 1, 2025, 06:09 ET
- Period: 2025-06-27
- Accession: 0001193125-25-153393
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1422143/000119312525153393/d911089d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1422143/000119312525153393/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1422143/000119312525153393/d911089d8k.htm

Filed Jul 1, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-153393. Last ingested by Listed: Nov 11, 2026, 03:30 ET. No prices; not investment advice.
